who should avoid glp-1 medications Are YOU a Slow/Non-Responder to GLP-1's? GLP-1 Meds: What They Really

The pathogenesis of gastroparesis as a disease involves neuronal changes resulting in an altered secretion of neuronal NO synthase (nNOS), VIP, substance P and expression of tyrosine hydroxylase

Skin has some natural ability to retract, especially in younger patients

At minimum, drop one dose level from your previous maintenance dose

doi: 10.1038/s41582-019-0174-4

For the main analysis, they focused on 821 people who had used a GLP-1 medication and compared current users with former users

The enhanced leptin transgene expression is evoked by injection of rAAV-lep into various hypothalamic sites, including the LHA, ARC, and PVN (Koyama et al., 2009)